AR023807A1 - Un agente para tratar el ojo seco y el uso de un compuesto macrolido para preparar composiciones farmaceuticas para el tratamiento del ojo seco - Google Patents
Un agente para tratar el ojo seco y el uso de un compuesto macrolido para preparar composiciones farmaceuticas para el tratamiento del ojo secoInfo
- Publication number
- AR023807A1 AR023807A1 ARP000102060A ARP000102060A AR023807A1 AR 023807 A1 AR023807 A1 AR 023807A1 AR P000102060 A ARP000102060 A AR P000102060A AR P000102060 A ARP000102060 A AR P000102060A AR 023807 A1 AR023807 A1 AR 023807A1
- Authority
- AR
- Argentina
- Prior art keywords
- dry eye
- agent
- pharmaceutical compositions
- compound
- macrolid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Abstract
La presente provee un agente para tratar el ojo seco, que contiene un compuesto macrolido tal como el FK 506, de formula (1). También se describe el uso dedichos macrolidos para la preparacion de las composiciones farmacéuticas destinadas al tratamiento del ojo seco.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13200999P | 1999-04-30 | 1999-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR023807A1 true AR023807A1 (es) | 2002-09-04 |
Family
ID=22452015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000102060A AR023807A1 (es) | 1999-04-30 | 2000-04-28 | Un agente para tratar el ojo seco y el uso de un compuesto macrolido para preparar composiciones farmaceuticas para el tratamiento del ojo seco |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1173177B2 (es) |
JP (2) | JP5036934B2 (es) |
KR (1) | KR20020015316A (es) |
CN (1) | CN1190194C (es) |
AR (1) | AR023807A1 (es) |
AT (1) | ATE281167T1 (es) |
AU (1) | AU777915B2 (es) |
BR (1) | BR0011225A (es) |
CA (1) | CA2372448A1 (es) |
CZ (1) | CZ20013769A3 (es) |
DE (1) | DE60015516T2 (es) |
ES (1) | ES2232439T3 (es) |
HK (2) | HK1043321B (es) |
HU (1) | HUP0200864A3 (es) |
IL (1) | IL146162A0 (es) |
MX (1) | MXPA01010988A (es) |
NO (1) | NO20015288D0 (es) |
NZ (1) | NZ515339A (es) |
PT (1) | PT1173177E (es) |
TR (1) | TR200103119T2 (es) |
TW (1) | TWI230066B (es) |
WO (1) | WO2000066122A1 (es) |
ZA (1) | ZA200108905B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2372448A1 (en) * | 1999-04-30 | 2000-11-09 | Sucampo Ag | Use of macrolide compounds for the treatment of dry eye |
US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
CA2452372A1 (en) | 2001-07-06 | 2003-01-16 | Sucampo Ag | Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
AR038628A1 (es) * | 2002-03-04 | 2005-01-19 | Novartis Ag | Composicion oftalmica |
US20050239813A1 (en) * | 2002-08-09 | 2005-10-27 | Sucampo Pharmaceuticals Inc. | Pharmaceutical compositions comprising fk506 derivatives and their use for the treatment of allergic diseases |
US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
WO2004062669A1 (en) * | 2003-01-16 | 2004-07-29 | Sucampo Ag | Use of a macrolide compound for treating dry eye |
US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
US7083802B2 (en) | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US7087237B2 (en) | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
WO2005032534A1 (ja) | 2003-10-06 | 2005-04-14 | Ophtecs Corporation | 涙液異常の治療のための眼科用組成物 |
US20060258698A1 (en) | 2005-02-09 | 2006-11-16 | Sreenivasu Mudumba | Liquid formulations for treatment of diseases or conditions |
EP1904056B1 (en) | 2005-07-18 | 2009-04-29 | Minu, L.L.C. | Use of a macrolide to restore corneal sensation |
US8492400B2 (en) | 2006-02-09 | 2013-07-23 | Santen Pharmaceutical Co., Ltd. | Stable formulations, and methods of their preparation and use |
JP5506378B2 (ja) | 2006-03-23 | 2014-05-28 | 参天製薬株式会社 | 血管透過性に関連する疾患または病気のための製剤および方法 |
EP2335735A1 (en) * | 2009-12-14 | 2011-06-22 | Novaliq GmbH | Pharmaceutical composition for treatment of dry eye syndrome |
US20200147055A1 (en) * | 2017-05-30 | 2020-05-14 | Eximore Ltd. | Compositions and methods for treating dry eye syndrome delivering antibiotic macrolide |
WO2019060696A1 (en) | 2017-09-25 | 2019-03-28 | Surface Pharmaceuticals, Inc. | OPTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR SURFACE DISEASE |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0406791T3 (da) * | 1989-07-05 | 1995-03-27 | Fujisawa Pharmaceutical Co | Vandigt flydende præparat til ekstern anvendelse |
ATE198708T1 (de) * | 1991-04-26 | 2001-02-15 | Fujisawa Pharmaceutical Co | Verwendung von makrolid-verbindungen gegen augenerkrankungen |
IL102414A (en) * | 1991-07-25 | 1996-08-04 | Univ Louisville Res Found | Medicinal preparations for the treatment of ocular inflammation, containing rapamycin |
AR004480A1 (es) * | 1995-04-06 | 1998-12-16 | Amico Derin C D | Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen |
GB9601120D0 (en) * | 1996-01-19 | 1996-03-20 | Sandoz Ltd | Organic compounds |
JP2002509555A (ja) * | 1998-04-06 | 2002-03-26 | 藤沢薬品工業株式会社 | 新規用途 |
ID29262A (id) * | 1998-04-27 | 2001-08-16 | Fujisawa Pharmaceutical Co | Komposisi farmasi |
US6376517B1 (en) * | 1998-08-14 | 2002-04-23 | Gpi Nil Holdings, Inc. | Pipecolic acid derivatives for vision and memory disorders |
CA2372448A1 (en) * | 1999-04-30 | 2000-11-09 | Sucampo Ag | Use of macrolide compounds for the treatment of dry eye |
-
2000
- 2000-04-26 CA CA002372448A patent/CA2372448A1/en not_active Abandoned
- 2000-04-26 KR KR1020017013768A patent/KR20020015316A/ko not_active Application Discontinuation
- 2000-04-26 CN CNB008067686A patent/CN1190194C/zh not_active Expired - Fee Related
- 2000-04-26 TW TW089107899A patent/TWI230066B/zh not_active IP Right Cessation
- 2000-04-26 MX MXPA01010988A patent/MXPA01010988A/es active IP Right Grant
- 2000-04-26 JP JP2000615007A patent/JP5036934B2/ja not_active Expired - Fee Related
- 2000-04-26 ES ES00921047T patent/ES2232439T3/es not_active Expired - Lifetime
- 2000-04-26 PT PT00921047T patent/PT1173177E/pt unknown
- 2000-04-26 NZ NZ515339A patent/NZ515339A/xx unknown
- 2000-04-26 WO PCT/JP2000/002756 patent/WO2000066122A1/en not_active Application Discontinuation
- 2000-04-26 AU AU41429/00A patent/AU777915B2/en not_active Ceased
- 2000-04-26 CZ CZ20013769A patent/CZ20013769A3/cs unknown
- 2000-04-26 TR TR2001/03119T patent/TR200103119T2/xx unknown
- 2000-04-26 EP EP00921047.7A patent/EP1173177B2/en not_active Expired - Lifetime
- 2000-04-26 IL IL14616200A patent/IL146162A0/xx unknown
- 2000-04-26 BR BR0011225-9A patent/BR0011225A/pt not_active IP Right Cessation
- 2000-04-26 DE DE60015516T patent/DE60015516T2/de not_active Expired - Lifetime
- 2000-04-26 HU HU0200864A patent/HUP0200864A3/hu unknown
- 2000-04-26 AT AT00921047T patent/ATE281167T1/de active
- 2000-04-28 AR ARP000102060A patent/AR023807A1/es not_active Application Discontinuation
-
2001
- 2001-10-29 ZA ZA200108905A patent/ZA200108905B/xx unknown
- 2001-10-29 NO NO20015288A patent/NO20015288D0/no not_active Application Discontinuation
-
2002
- 2002-07-12 HK HK02105192.3A patent/HK1043321B/zh not_active IP Right Cessation
- 2002-10-24 HK HK02107726.4A patent/HK1046099A1/zh unknown
-
2012
- 2012-02-03 JP JP2012022420A patent/JP2012116857A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
NO20015288L (no) | 2001-10-29 |
BR0011225A (pt) | 2002-03-19 |
TWI230066B (en) | 2005-04-01 |
AU4142900A (en) | 2000-11-17 |
ES2232439T3 (es) | 2005-06-01 |
NZ515339A (en) | 2004-02-27 |
JP5036934B2 (ja) | 2012-09-26 |
CA2372448A1 (en) | 2000-11-09 |
IL146162A0 (en) | 2002-07-25 |
CN1190194C (zh) | 2005-02-23 |
HUP0200864A2 (hu) | 2002-07-29 |
CZ20013769A3 (cs) | 2002-03-13 |
HUP0200864A3 (en) | 2004-07-28 |
ATE281167T1 (de) | 2004-11-15 |
KR20020015316A (ko) | 2002-02-27 |
EP1173177A1 (en) | 2002-01-23 |
JP2002543132A (ja) | 2002-12-17 |
MXPA01010988A (es) | 2004-04-21 |
ZA200108905B (en) | 2002-12-24 |
EP1173177B2 (en) | 2014-03-05 |
DE60015516D1 (de) | 2004-12-09 |
NO20015288D0 (no) | 2001-10-29 |
HK1043321A1 (en) | 2002-09-13 |
HK1046099A1 (zh) | 2002-12-27 |
HK1043321B (zh) | 2005-07-15 |
DE60015516T2 (de) | 2005-12-01 |
WO2000066122A1 (en) | 2000-11-09 |
EP1173177B1 (en) | 2004-11-03 |
JP2012116857A (ja) | 2012-06-21 |
TR200103119T2 (tr) | 2002-04-22 |
PT1173177E (pt) | 2005-03-31 |
AU777915B2 (en) | 2004-11-04 |
CN1353608A (zh) | 2002-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR023807A1 (es) | Un agente para tratar el ojo seco y el uso de un compuesto macrolido para preparar composiciones farmaceuticas para el tratamiento del ojo seco | |
ECSP003682A (es) | Compuestos para el tratamiento de la isquemia | |
PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
BRPI0113042B8 (pt) | composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato | |
BR0215052A (pt) | Composições acaricidas e métodos | |
PA8468401A1 (es) | Compuestos para el tratamiento de la isquemia | |
AR006867A1 (es) | Composición topica para la piel que comprende un compuesto oxa-diácido, su uso para preparar un medicamento para tratar condiciones de la piel y métodos cosméticos no terapéuticos para el pulido de la piel y para suavizar el cabello que aplican dicho compuesto. | |
BR9812122A (pt) | Combinação de inibidor da tirosina quinase e castração quìmica para tratar câncer da próstata | |
BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
BR0200782A (pt) | Compostos para o tratamento da isquemia | |
ES2065471T3 (es) | Composiciones acuosas antibacterianas que comprenden un tensoactivo y bacteriofagos. | |
ES2186015T3 (es) | Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol. | |
ES2044912T3 (es) | Composiciones farmaceuticas dotadas de actividad secuestrante para los acidos biliares, conteniendo colestiramina como principio activo, y procedimiento para su preparacion. | |
ECSP034924A (es) | Derivados sustituidos del 1-oxa-2,8-daza-espiro[4,5]dec-2-eno | |
PT1056454E (pt) | Utilizacao de compostos macrolido para o tratamento do glaucoma | |
AR003427A1 (es) | Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas. | |
ES2178036T3 (es) | Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen. | |
ES2243579T3 (es) | Derivados de pirazolopirideno. | |
PA8485601A1 (es) | Azalidas de 13 miembros y su uso como agentes antibioticos. | |
BR9507730A (pt) | Uso de formulações em gel como composições de tratamento | |
AR007021A1 (es) | Derivados de 3-descladinosa-2,3-anhidroeritromicina, procedimientos para su preparacion, compuestos para su exclusivo uso en dichos procedimientosy procedimiento para su preparacion, una composicion farmaceutica para tratar infecciones bacterianas y el uso de estos compuestos para preparar medicamentos | |
ES2194535T3 (es) | 4-trifluorometil-3-oxazolilpiridinas, procedimiento para su preparacion, agentes que las contien y su uso como agente parala lucha contra organismos dañinos. | |
AR018162A1 (es) | Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica | |
BR0010983A (pt) | Preparações para a aplicação de agentes antiinflamatórios | |
BR9911559A (pt) | Processo para a preparação de um composto, composto, processo para o tratamento de tumores resistentes a medicamento múltiplo, uso de um composto, e, agente e composição para tratar tumores resistentes a medicamento múltiplo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |